Research Update: GlobalFoundries Singapore Pte. Ltd. Ratings Withdrawn At Issuer's Request Dec 11

  • ID: 2029949
  • December 2011
  • Region: Singapore
  • Standard & Poors
1 of 3

On Dec 9, 2011, Standard & Poor's Ratings Services withdrew its 'BB' corporate credit rating, 'BB' senior unsecured rating, and all issue-level ratings on GLOBALFOUNDRIES Singapore Pte. Ltd., at the issuer's request. GLOBALFOUNDRIES Singapore is a direct subsidiary of unrated and privately owned GLOBALFOUNDRIES. Not Rated Action; Outlook Action To From GlobalFoundries Singapore Pte. Ltd. Corporate Credit Rating NR/-- BB/Stable/-- Not Rated Action To From GlobalFoundries Singapore Pte. Ltd. Senior Unsecured NR BB Recovery Rating NR 3...

Companies mentioned in this report are: GlobalFoundries Singapore Pte. Ltd.
Action: Withdrawn

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Product Type: Research Update
Research updates complement media releases. They offer more depth and detail than summary analyses by incorporating all information published in the media release. They are more up to date than summaries in that they are published simultaneously with media releases.

Note: Product cover images may vary from those shown
2 of 3

GlobalFoundries Singapore Pte. Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.